ENTERTAINMENT
November 28, 2006 | Michael Harris, Special to The Times
WHEN we last heard from Michael Crichton, he had grown a giant-size petri dish full of controversy with his 2004 novel, "State of Fear," the premise of which was that global warming was a hoax used to justify acts of eco-terrorism. The White House cozied up to Crichton and his ideas; most scientists in the field were unimpressed.
NEWS
May 18, 1996 | THOMAS H. MAUGH II, TIMES MEDICAL WRITER
Sometime this fall, English researchers will take the heart of a genetically engineered pig and implant it in a human whose own heart is dying. It will not be the first time surgeons have attempted to use an animal organ in a human. But it may well be the first time such a transplant succeeds because researchers have given the pig heart human genes that make it less likely to be rejected.
NEWS
April 27, 1999 | From Times Wire Reports
Researchers said they succeeded in genetically engineering goats to produce a human protein used to affect blood clotting, then cloned the goats. The researchers from Framingham, Mass.-based Genzyme Transgenics Corp., Tufts University and Louisiana State University said three cloned female goats were born last fall. It is the first report of a goat being cloned, although goats commonly are genetically engineered to produce human proteins in their milk.
BUSINESS
May 12, 1994 | From Reuters
The brave new world of biotechnological engineering moved to the farm this month--via a herd of specially bred goats whose owners say will be capable of producing proteins at a tenth of the cost of current methods. Genzyme Transgenics Corp., which uses specially produced proteins to make prescription drugs and diagnostic products, said last week that it has taken possession of a 166-acre farm in western Massachusetts.
ENTERTAINMENT
May 3, 2002 | SCOTT SANDELL, TIMES STAFF WRITER
Bad day at the office? Try this: Show up for work late. When you do arrive, help half a dozen of your friends hold the place hostage. Then reveal to the boss and the rest of the world that you're a genetically engineered, bar-coded escapee from a secret Wisconsin laboratory.
BUSINESS
February 9, 2000 | Bridge News
The new biotech rush is on. Is it a prescription for disaster? With biotechnology stocks sizzling, start-ups are scrambling to get in on the action. According to Prudential Securities analyst Caroline Copithorne, 11 biotechs have filed already this year to make initial public offerings. That compares with 11 biotech companies for the entire 1999 calendar year. Genomics stocks have led the biotech sector's charge. Affymetrix Inc.